ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc.
ANIP
Valuace
30
Růst
100
Zdraví
68
Cena
$ 89.13
Dnes
--0.46 (-0.54%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.9B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
8%
ROA
3%
PE
21
PS
2
Cena 1R
54-100
⌀ Cena
78.11
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
27-02-2026
Poslední dividenda

Profil

ANI Pharmaceuticals, Inc., biofarmaceutická společnost, vyvíjí, vyrábí a prodává značková a generická léčiva na předpis ve Spojených státech a Kanadě. Zaměřuje se na výrobu regulovaných látek, onkologických přípravků, hormonů a steroidů, injekčních a dalších přípravků. Společnost vyrábí přípravky pro orální dávkování pevných látek, polotuhé látky, kapaliny a témata a účinné přípravky, jakož i provádí vývoj smluv a výrobu farmaceutických výrobků pro jiné společnosti. Své výrobky prodává prostřednictvím maloobchodních lékárenských řetězců, velkoobchodníků, distributorů a lékáren na objednávku zásilek a skupinových nákupních organizací. Společnost byla založena v roce 2001 a sídlí v Baudette v Minnesotě.
Sektor
Healthcare
Odvětví
Drug Manufacturers - Specialty & Generic
Počet zaměstnanců
897
Založení
2000-05-05
Adresa
210 Main Street West
CEO
Nikhil Lalwani

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues883.4883.4614.4486.8316.4216.1208.5206.5201.6176.8128.676.356.030.12.30.42.5
Cost of Revenues273.2432.7250.2181.5138.8100.687.263.273.079.048.812.711.510.00.00.10.3
Gross Profit610.2450.6364.2305.3177.6115.5121.3143.4128.697.879.863.644.520.12.30.42.2
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues247.1227.8211.4197.1190.6148.3138.0137.4131.7131.8
Cost of Revenues9.5116.074.673.080.363.157.749.268.648.1
Gross Profit237.6111.8136.8124.1110.385.380.388.363.083.7
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.034.322.311.416.019.815.49.12.92.92.71.716.944.239.7
Selling General & Admin Expenses0.00.00.0161.7124.084.365.055.844.131.627.821.217.916.48.27.05.9
Depreciation & Amortization91.491.467.759.857.047.344.644.533.727.922.36.93.91.10.30.10.2
Total Operating Expenses499.1369.4363.6258.3203.3143.7136.9127.093.268.653.130.924.519.225.551.345.8
Operating Income111.181.20.647.0-25.1-32.5-16.116.435.428.320.132.720.00.9-23.2-50.9-43.6
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.09.911.1
Selling General & Admin Expenses0.00.00.00.00.00.00.00.044.542.0
Depreciation & Amortization22.622.623.322.922.615.714.714.715.216.0
Total Operating Expenses189.489.0122.997.9114.7105.875.268.054.368.3
Operating Income48.222.813.926.2-4.4-20.55.220.38.717.9
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income10.80.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Interest Expense43.920.117.626.928.111.99.513.014.812.011.311.00.80.50.30.70.7
Other Expense-15.314.6-22.8-27.1-37.6-23.5-9.9-13.2-0.6-0.8-6.80.00.2-0.3-4.30.0-1.9
IBT95.895.8-22.219.9-62.7-56.1-26.03.220.116.38.721.719.40.1-27.8-51,608.5-46,196.2
Income Tax Expense17.517.5-3.71.1-14.8-13.5-3.4-2.94.617.44.76.4-9.40.0-0.10.72.6
Net Income75.978.3-18.518.8-47.9-42.6-22.56.115.5-1.13.915.428.70.3-27.7-51.6-46.2
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income5.40.02.82.60.00.00.00.00.06.4
Interest Expense22.84.78.28.16.02.34.74.65.66.4
Other Expense-16.711.0-3.4-6.2-9.4-11.0-7.55.0-5.8-6.4
IBT31.533.810.520.0-13.8-31.5-2.325.30.911.5
Income Tax Expense4.07.22.04.3-3.5-7.30.07.1-0.21.6
Net Income27.524.18.515.7-10.3-24.2-2.318.21.29.9
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$0.95$-2.95$-3.38$-1.88$0.51$1.33$-0.09$0.34$1.34$2.61$-0.92$-7.64$-18.88$-25.23
EPS Diluted$0.00$0.00$0.00$0.94$-2.95$-3.38$-1.88$0.50$1.32$-0.09$0.34$1.32$2.59$-0.92$-7.64$-18.88$-25.23
Shares Outstanding20.120.119.318.016.312.612.011.811.711.511.411.410.95.13.62.71.8
Diluted Shares Outstanding21.221.219.318.216.312.612.012.011.811.511.611.611.15.13.62.71.8
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.04$0.50
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.04$0.50
Shares Outstanding20.120.119.819.619.419.419.319.119.018.9
Diluted Shares Outstanding21.221.120.320.019.419.419.319.419.219.1
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents240.1144.9221.148.2100.37.962.343.031.127.4154.7169.011.134.857.238.2
Short Term Investments6.96.30.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments247.1151.2221.148.2100.37.962.343.031.127.4154.7169.011.134.857.238.2
Accounts Receivable166.1221.7162.1165.4128.595.872.164.858.845.921.917.312.50.00.00.0
Inventory125.4136.8111.2105.481.760.848.240.537.726.213.47.53.50.00.00.0
Other Current Assets16.618.025.48.411.35.95.14.52.83.61.52.027.70.40.82.5
Total Current Assets555.2527.7519.8344.3321.8170.3187.7152.9131.6103.0192.6203.527.735.258.040.6
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents262.6217.8149.8144.9145.0240.1228.6221.1193.1161.7
Short Term Investments0.05.75.46.38.36.99.70.00.00.0
Total Cash & ST Investments262.6223.5155.2151.2153.3247.1238.3221.1193.1161.7
Accounts Receivable252.6225.7220.3221.7196.4166.1172.4162.1178.8172.9
Inventory146.5138.3137.4136.8148.0125.4113.8111.2106.6104.3
Other Current Assets36.715.123.418.023.616.916.142.629.220.4
Total Current Assets698.4602.6536.3527.7521.3555.5540.6519.6497.2459.3
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment51.656.944.643.252.741.340.638.120.411.07.15.24.50.20.90.6
Goodwill28.260.028.228.227.93.63.63.61.81.81.81.81.80.00.00.0
Intangible Assets183.1541.8209.0251.6294.1188.5180.4201.6229.8175.866.442.110.40.00.00.0
Long-Term Investments7.40.00.00.00.00.00.00.00.80.00.00.00.03.43.43.5
Other Long-Term Assets5.712.212.111.47.25.86.26.55.05.00.03.30.00.00.10.0
Total Long-Term Assets365.6756.0384.6415.8449.8290.9269.1277.7280.5219.992.760.216.83.64.44.1
Total Assets920.81,283.7904.4760.1771.6461.2456.8430.6412.1322.9285.3263.744.538.862.444.8
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment63.659.258.256.956.751.648.544.644.244.4
Goodwill62.560.560.760.060.428.228.228.228.228.2
Intangible Assets499.8520.3538.5541.8569.8183.1196.0209.0219.8230.3
Long-Term Investments0.00.00.00.00.00.00.06.210.09.2
Other Long-Term Assets12.58.210.312.211.512.813.66.16.16.5
Total Long-Term Assets709.8740.4756.1756.0766.1365.3374.0384.8392.7400.0
Total Assets1,408.21,343.01,292.41,283.71,287.4920.8914.5904.4889.9859.3
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable48.745.736.729.323.011.314.68.93.63.42.12.71.41.13.24.9
Short-Term Debt0.99.22.40.90.913.29.9115.73.40.00.00.01.37.90.01.1
Other Current Liabilities87.6132.198.269.363.654.036.740.28.328.69.710.60.71.64.12.2
Current Liabilities140.0193.7145.599.487.578.661.7165.539.231.911.813.23.510.67.28.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable69.854.653.145.760.948.749.436.734.128.5
Short-Term Debt15.213.211.29.27.20.90.92.40.90.9
Other Current Liabilities176.3165.8123.4132.1121.990.475.298.298.889.4
Current Liabilities270.6236.8201.8193.7189.9140.0136.9145.5134.4122.9
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt309.2614.9284.8285.7286.5172.4175.867.3198.2120.6113.4110.70.00.017.317.4
Capital Leases4.70.04.80.00.00.00.00.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.081.40.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities465.0855.2446.8421.5412.9265.5244.0233.3237.4153.2125.2123.93.510.624.625.6
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt307.4608.3611.6614.9618.2284.4284.6289.6290.3290.0
Capital Leases0.00.00.00.00.00.00.04.85.34.7
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities902.3881.4849.0855.2856.6440.1437.7471.7435.2424.9
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.0273.1255.1184.8
Retained Earnings-65.0-100.3-80.1-97.3-47.8-5.017.611.5-4.0-2.9-4.4-19.7-48.5-245.0-217.2-165.6
Comprehensive Income8.35.38.912.2-3.1-11.4-4.9-0.4-6.6-5.4-4.5-3.8-3.2-0.4-0.4-0.4
Total Common Equity455.8428.5432.7338.5358.7195.7212.8197.3174.8169.6160.1139.841.028.237.819.1
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-50.6-76.9-85.0-100.3-89.6-65.0-62.3-80.1-80.9-90.4
Comprehensive Income2.83.33.65.35.48.39.48.914.113.7
Total Common Equity505.8461.6443.5428.5430.8480.6476.8432.7454.7434.5
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt310.1624.1285.7286.5287.4185.7185.7183.0201.5120.6113.4110.70.07.917.318.5
Book Value455.8428.5457.6338.5358.7195.7212.8197.3174.8169.6160.1139.841.028.237.819.1
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value505.8461.6443.5428.5430.8480.6476.8432.7454.7434.5
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income25.278.3-18.518.8-47.9-42.6-22.56.115.5-1.13.915.428.70.3-27.7-51.6-46.2
Depreciation & Amortization59.891.467.759.859.747.344.644.633.727.922.36.93.91.10.30.10.2
Stock-Based Compensation25.937.929.320.714.610.512.99.26.86.16.13.93.44.50.71.21.0
Change Working Capital18.6-7.1-11.224.9-51.3-0.1-12.6-14.66.0-5.7-9.9-13.9-0.1-11.4-3.91.82.8
Change In Accounts Receivable6.8-58.5-21.13.4-36.9-5.5-23.7-7.3-4.7-12.9-24.0-4.6-4.8-7.10.00.00.1
Change In Accounts Payable18.715.20.57.65.010.2-2.35.03.50.01.1-1.00.2-0.6-4.4134.13,142.1
Change In Inventories-21.1-6.0-21.3-5.8-23.63.2-2.8-7.7-0.45.4-1.9-5.9-3.5-0.70.00.0-3,171.8
Other Non-cash Items74.9-29.618.66.69.05.06.19.410.38.614.06.90.60.24.3-51.41.9
Cash from Operations112.60.00.0119.0-31.23.315.345.667.139.427.517.322.0-5.5-25.3-47.9-40.1
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income27.526.68.515.7-10.3-24.2-2.318.21.29.9
Depreciation & Amortization22.622.623.322.922.615.714.714.715.215.2
Stock-Based Compensation9.89.79.68.97.17.57.96.95.65.4
Change Working Capital-26.9-17.836.21.3-4.814.6-4.5-10.227.85.6
Change In Accounts Receivable-27.9-27.0-5.51.8-25.58.46.3-10.316.8-5.9
Change In Accounts Payable-7.213.83.15.5-6.80.0-1.111.52.85.6
Change In Inventories3.7-8.2-0.9-0.6-0.7-6.4-11.6-2.6-4.6-2.3
Other Non-cash Items-5.0-15.91.7-10.418.8-1.23.5-14.43.3-0.7
Cash from Operations0.00.00.00.00.00.00.00.044.732.2
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-18.4-34.3-16.2-8.9-16.5-23.6-68.3-27.5-10.9-108.0-149.1-32.7-35.8-0.2-0.6-0.7-0.1
Acquisitions13.50.0-401.30.00.0-84.50.00.0-16.50.00.00.00.018.20.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Investing Activities2.40.00.0-9.60.82.60.00.00.00.0-5.00.00.02.30.00.00.0
Cash from Investing-4.80.00.0-18.5-15.7-105.5-68.3-27.5-27.4-108.0-154.1-32.7-35.820.3-0.6-0.7-0.1
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-9.4-6.1-4.0-2.5-2.4-4.8-4.4-4.6-4.8-4.6
Acquisitions0.00.00.00.0-8.2-393.10.00.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.0-2.5-2.8
Cash from Investing0.00.00.00.00.00.00.00.0-4.8-4.6
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-3.00.00.0-3.0-3.0-211.0-15.5-121.5-28.90.00.00.00.0-4.10.0-1.20.0
Debt Issued27.0624.1338.42.22.1312.715.5124.210.480.97.22.7110.7-3.8-9.50.018.5
Issuance of Common Stock11.10.00.080.60.075.00.00.00.00.00.00.046.70.03.368.848.5
Repurchase of Common Stock-10.9-12.2-11.0-5.0-2.0-0.9-1.5-1.0-0.7-0.3-0.1-0.10.0-0.40.00.00.0
Dividends Paid-1.60.00.0-1.6-1.6-0.20.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-19.80.00.0-3.51.5331.715.6123.71.872.6-0.61.2125.00.80.20.10.0
Cash from Financing-29.30.00.067.4-5.1194.6-1.41.3-27.872.4-0.71.1171.7-3.73.567.748.5
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-0.8-0.8
Debt Issued322.6-298.9-1.3-1.3-1.3340.1-0.2-29.930.20.5
Issuance of Common Stock0.00.00.00.00.00.00.00.00.05.6
Repurchase of Common Stock-0.60.00.0-10.0-0.3-0.7-1.3-8.7-0.2-0.7
Dividends Paid0.00.00.00.00.00.00.00.0-0.4-0.4
Other Financing Activities0.00.00.00.00.00.00.00.0-10.54.9
Cash from Financing0.00.00.00.00.00.00.00.0-11.93.8
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash78.4140.7-76.2167.9-52.192.4-54.519.311.93.8-127.3-14.4157.911.1-22.419.18.3
Closing Cash Balance240.1285.6144.9221.153.2105.312.967.448.036.227.4154.7169.011.134.857.238.2
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash23.044.868.04.9-0.1-95.111.57.528.031.4
Closing Cash Balance285.6262.6217.8149.8144.9145.0240.1228.6221.1193.1
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow94.2171.447.1100.4-47.7-20.3-53.118.156.2-68.6-121.6-15.4-13.7-5.7-25.9-48.6-40.2
Real Free Cash Flow68.4133.517.779.8-62.3-30.8-66.08.949.4-74.7-127.7-19.3-17.1-10.1-26.6-49.8-41.2
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow6.537.968.915.113.47.713.013.740.027.6
Real Free Cash Flow-3.328.259.36.36.30.25.16.834.322.2
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E20.9783.22356.8
P/S1.84.370.5
P/B3.13.22015.4
P/FCF17.50.77573.5
Market cap$1.9$1.0
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets22.9 %33.7 %0 %
Debt to Income425.3 %17924.1 %0 %
Debt to Free cash flow356.4 %-65.9 %0 %
Interest expense percentage39.5 %34.9 %26.2 %
Current ratio2.6 5.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE15 %-33.7 %0 %
ROA5.4 %-16.4 %0 %
CapEx to Revenue1.8 %40.6 %6 %
RaD to Revenue0 %1226.5 %0 %
ROEM984,800.4 227819.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin58.4 %70.9 %74.8 %
Operating margin7.1 %-1367.4 %35 %
Net margin4.6 %-1490.9 %34.1 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %-0.5 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding21.1 mil 11.1 mil
Employee count0.9 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader